Products

Primary tabs

Export products to Excel

Displaying 1 - 15 of 213
Product Alternative Name Development Status Target Modesort descending Active Pharmaceutical Ingredient (API) Delivery Type Duration Type Project Stage Partner Updated date
PLA/PLGA Injectable Microspheres Active Development Female Hormonal levonorgestrel Injectable Long-acting Pre-clinical Shanghai Institute of Planned Parenthood Research (SIPPR), FHI 360 05/30/2018
TU + NET-EN Testosterone undecanoate (TU) + norethisterone enanthate (NET-EN Inactive Male Hormonal testosterone undecanoate, norethisterone enanthate Injectable Long-acting Phase II Bayer HealthCare, CONRAD, WHO 05/30/2018
Biodegradable LNG-releasing Implant (Peking University) Female Hormonal levonorgestrel Subdermal Long-acting Pre-clinical Peking University, Institute of Biomedical Engineering at Chinese Academy of Medical College 05/30/2018
Omega LNG IUS Active Development Female Hormonal levonorgestrel Intrauterine Long-acting Regulatory Contrel Research, Belgium 05/30/2018
Biodegradable LNG-releasing Implant (SIPPR) Active Development Female Hormonal levonorgestrel Subdermal Long-acting Pre-clinical Shanghai Institute of Planned Parenthood Research (SIPPR) 05/30/2018
Liletta LNG IUS Levosert (U.K.), Erlacela (Portugal), Donasert (Romania) SRA/WHO PQ Approved Female Hormonal levonorgestrel Intrauterine Long-acting Marketed Actavis, Medicines360 05/30/2018
MENT Implant MENT Acetate Implant Active Development Male Hormonal 7alpha-Methyl-19-Nortestosterone Subdermal Long-acting Phase II Population Council 05/30/2018
Biodegradable Implant with [Poly(PDL-co-DO)] Co-polymers Active Development Female Hormonal levonorgestrel Subdermal Long-acting Pre-clinical FHI 360, Yale University 05/30/2018
Testosterone undecanoate (TU) TU, Aveed Inactive Male Hormonal testosterone undecanoate Injectable Short-acting Phase III Bayer HealthCare, National Research Institute for Family Planning in Beijing 05/30/2018
Norethindrone Acetate Patch Active Development Female Hormonal norethindrone Transdermal Short-acting Regulatory Actavis 05/30/2018
Biodegradable pHEMA-based Implant Active Development Female Hormonal levonorgestrel Subdermal Long-acting Pre-clinical University of Washington 05/30/2018
Gestodene and EE Patch FC-Patch low, Lisvy® SRA/WHO PQ Approved Female Hormonal ethinyl estradiol, gestodene Transdermal Short-acting Regulatory WHO HRP, Bayer HealthCare, Gedeon Richter Plc. 05/30/2018
LNG-encapsulated Injectable PLGA Microspheres Active Development Female Hormonal levonorgestrel Injectable Long-acting Pre-clinical Stanford University 07/21/2016
TU + ENG Testosterone undecanoate (TU) + etonogestrel (ENG) Inactive Male Hormonal testosterone undecanoate, etonogestrel Injectable, Subdermal Long-acting Phase II Organon 07/25/2016
Merck Biodegradable Implant Active Development Female Hormonal Subdermal Long-acting Merck 07/21/2016
Export to Excel